Therapeutic biologics company MiMedx has announced the appointment of William L Phelan as senior vice president and chief accounting officer, effective 1 May, 2020. Phelan is an accounting professional with more than 25 years of experience building, leading, and advising companies, and has worked with MiMedx in a consultative capacity for nearly two years.
Peter M Carlson, MiMedx chief financial officer, commented, “Phelan has already provided significant expertise throughout the restatement process. He has been critical to moving MiMedx towards becoming current in our financial reporting and strengthening the company’s internal controls. His interest in joining the company as a full-time employee is a testament to our commitment to transparency and a patient-centred culture.”
Prior to joining MiMedx, Phelan was a managing director for CFGI, a firm providing accounting, reporting, tax and compliance services. Before joining CFGI, he served as vice president and chief accounting officer at a Florida-based pharmaceutical company. Phelan holds a Bachelor of Science in Accounting from Shippensburg University and a Master of Business Administration from Penn State University. He is licensed as a certified public accountant in Pennsylvania, and a member of multiple accounting industry associations.